Ignite Creation Date:
2024-05-06 @ 2:19 AM
Last Modification Date:
2024-10-26 @ 11:16 AM
Study NCT ID:
NCT02014142
Status:
COMPLETED
Last Update Posted:
2017-01-18
First Post:
2013-12-12
Brief Title:
A Phase 2 Single-Masked Randomized Study of Latanoprost PPDS in Ocular Hypertension or Open-Angle Glaucoma
Sponsor:
Mati Therapeutics Inc
Organization:
Mati Therapeutics Inc
Study Overview
Official Title:
A Phase 2 Single-Masked Randomized Study of the Latanoprost Punctal Plug Delivery System L-PPDS in Subjects With Ocular Hypertension or Open-Angle Glaucoma
Status:
COMPLETED
Status Verified Date:
2017-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Determine efficacy of the latanoprost punctal plug Effect of configuration of L-PPDS placement on efficacy will also be examined
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None